Skip Navigation

JNCI Journal of the National Cancer Institute 2008 100(1):1; doi:10.1093/jnci/djm296
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Japanese Translation, Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Search for Related Content
Related Collections
Right arrowRelated Articles in JNCI
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© Oxford University Press 2007.

IN THIS ISSUE

The first 10% of the full text of this article appears below.

Early Breast Cancer, HER2 Status, and Adjuvant Anthracyclines

In the treatment of early breast cancer, anthracycline-based adjuvant chemotherapy improves disease-free and overall survival compared with non–anthracycline-based adjuvant chemotherapy. However, it is unclear whether the response depends on the HER2 status of the breast tumors. Gennari et al. (p. 14) performed a pooled analysis of data from eight randomized controlled trials that compared anthracycline-based with non–anthracycline-based adjuvant chemotherapy regimens in early breast cancer treatment. The analysis included 6,564 randomly assigned patients, 5,354 of whom had HER2 status information available. Anthracyclines were superior to non–anthracyclines in terms of disease-free and overall survival . . . [Full Text of this Article]

Systemic Adjuvant Therapy and Contralateral Breast Cancer Risk

Quality of Care for Nursing Home Residents Treated for Cancer

Environmental Influences on Risk for Testicular Cancer in Denmark

DNA Breakpoint Information and Breast Cancer Recurrence

Cannabinoid Treatment and Cancer Cell Invasiveness In Vitro


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?

Related Articles in JNCI

IN THIS ISSUE
J Natl Cancer Inst 2008 100: 1. [Extract] [Full Text] [PDF]

HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials
Alessandra Gennari, Maria Pia Sormani, Paolo Pronzato, Matteo Puntoni, Mariantonietta Colozza, Ulrich Pfeffer, and Paolo Bruzzi
J Natl Cancer Inst 2008 100: 14-20. [Abstract] [Full Text] [PDF]

High-Resolution Mapping of DNA Breakpoints to Define True Recurrences Among Ipsilateral Breast Cancers
Marc A. Bollet, Nicolas Servant, Pierre Neuvial, Charles Decraene, Ingrid Lebigot, Jean-Philippe Meyniel, Yann De Rycke, Alexia Savignoni, Guillem Rigaill, Philippe Hupé, Alain Fourquet, Brigitte Sigal-Zafrani, Emmanuel Barillot, and Jean-Paul Thiery
J Natl Cancer Inst 2008 100: 48-58. [Abstract] [Full Text] [PDF]

Effect of Systemic Adjuvant Treatment on Risk for Contralateral Breast Cancer in the Women's Environment, Cancer and Radiation Epidemiology Study
Lisbeth Bertelsen, Leslie Bernstein, Jørgen H. Olsen, Lene Mellemkjær, Robert W. Haile, Charles F. Lynch, Kathleen E. Malone, Hoda Anton-Culver, Jane Christensen, Bryan Langholz, Duncan C. Thomas, Colin B. Begg, Marinela Capanu, Bent Ejlertsen, Marilyn Stovall, John D. Boice, Jr, Roy E. Shore, The Women's Environment, Cancer and Radiation Epidemiology Study Collaborative Group, and Jonine L. Bernstein
J Natl Cancer Inst 2008 100: 32-40. [Abstract] [Full Text] [PDF]

Inhibition of Cancer Cell Invasion by Cannabinoids via Increased Expression of Tissue Inhibitor of Matrix Metalloproteinases-1
Robert Ramer and Burkhard Hinz
J Natl Cancer Inst 2008 100: 59-69. [Abstract] [Full Text] [PDF]

Absence of Cancer Diagnosis and Treatment in Elderly Medicaid-Insured Nursing Home Residents
Cathy J. Bradley, Jan P. Clement, and Chunchieh Lin
J Natl Cancer Inst 2008 100: 21-31. [Abstract] [Full Text] [PDF]

Testicular Cancer Risk in First- and Second-Generation Immigrants to Denmark
Charlotte Myrup, Tine Westergaard, Tine Schnack, Anna Oudin, Christian Ritz, Jan Wohlfahrt, and Mads Melbye
J Natl Cancer Inst 2008 100: 41-47. [Abstract] [Full Text] [PDF]

Older Survivors and Cancer Care
Noreen M. Aziz and Keith Bellizzi
J Natl Cancer Inst 2008 100: 4-5. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
 JNCI J Natl Cancer InstHome page
M. J. Thun, L. M. Hannan, and M. Stefanek
Risky Business: Tools to Improve Risk Communication in a Doctor's Office
J Natl Cancer Inst, June 18, 2008; 100(12): 830 - 831.
[Full Text] [PDF]